Rapid response with good toleration of sirolimus for life-threatening neonatal lymphatic malformations.
Shixiao DongLi LiJiaosheng XuZhonglong HanXia ZhengPublished in: Pediatric investigation (2023)
Sirolimus can be considered a promising choice for neonates with intricate and life-threatening LMs. Initiation with a reduced sirolimus dose is advisable.